Fundraising Fox

Stylus Medicine

5 known investors

stylusmedicine.com ↗

Stylus Medicine develops in vivo genetic medicines using engineered recombinases, with initial focus on creating CAR-T therapies delivered via lipid nanoparticles for oncology, autoimmune, and genetic diseases.

BiotechDigital HealthMedical Devices

Founders & leadership

MC
Michael C. Bassik, Ph.D.inScientific Founder
EN
Emile Nuwaysir, Ph.D.inChairman & Chief Executive Officer
JFJason Fontenot, Ph.D.
Jason Fontenot, Ph.D.Chief Scientific Officer

Investors · 5

Brainstorm VenturesSan Francisco
Khosla VenturesMenlo Park · $5K – $50M
Neva Sgr.Turin
Tachyon VenturesLos Angeles
RA CapitalreportedBoston

In the news